No Data
Insmed Ranks No. 1 on Science's 2024 Top Biopharma Employers List
Peering Into Insmed's Recent Short Interest
Insmed Unites Across Communities Around the World During Third Annual Global Day of Good
Insmed to Host Third-Quarter 2024 Financial Results Conference Call on Thursday, October 31, 2024
Here's How Much $100 Invested In Insmed 10 Years Ago Would Be Worth Today
Insmed Price Target Raised to $100.00/Share From $85.00 by Truist Securities